Issue Date
2021-02-07Keywords
RAS in human cancerRAS oncogene
RAS signaling networks
computational modeling
Personalized therapies
Targeting RAS
Metadata
Show full item recordJournal
BiomoleculesDOI
10.3390/biom11020236PubMed ID
33562401Item Type
ArticleLanguage
enEISSN
2218-273Xae974a485f413a2113503eed53cd6c53
10.3390/biom11020236
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Related articles
- RAS mutations in human cancers: Roles in precision medicine.
- Authors: Murugan AK, Grieco M, Tsuchida N
- Issue date: 2019 Dec
- Molecular pathways: targeting RAC-p21-activated serine-threonine kinase signaling in RAS-driven cancers.
- Authors: Baker NM, Yee Chow H, Chernoff J, Der CJ
- Issue date: 2014 Sep 15
- The greedy nature of mutant RAS: a boon for drug discovery targeting cancer metabolism?
- Authors: Lv J, Wang J, Chang S, Liu M, Pang X
- Issue date: 2016 Jan
- RAS-mediated oncogenic signaling pathways in human malignancies.
- Authors: Khan AQ, Kuttikrishnan S, Siveen KS, Prabhu KS, Shanmugakonar M, Al-Naemi HA, Haris M, Dermime S, Uddin S
- Issue date: 2019 Feb
- RAS signaling and anti-RAS therapy: lessons learned from genetically engineered mouse models, human cancer cells, and patient-related studies.
- Authors: Fang B
- Issue date: 2016 Jan